Vaccine(7) neutralization(6) Patient(6) utility(6) mAb(6) agency(6) Treatment(6) reduced(6) Vaccines(6) EUA(6) small molecule(6) Nonclinical(6) Candidates(6) performed(6) vaccination(6) monoclonal antibody(6) pathway(6) development(6) pharmacokinetic(6) authorization(6) SARS-CoV-2(6) the spike protein(6) antibody(6) Regulatory(6) USA(6) monoclonal(6) Recognition(6) COVID-19(6) occurred(6) therapy(6)